Characteristics | Synbiotics (N=30) | Placebo (N=30) | p value |
---|---|---|---|
Gender, n(%) | |||
 Male | 10 (33.3) | 11 (36.7) | 0.787a |
 Female | 20 (66.7) | 19 (63.3) |  |
 Age (years), mean (SD) | 51.23 (13.57) | 52.33 (11.29) | 0.734b |
HD duration (months), median (IQR) | 70.50 (46.25-118.75) | 57.50 (29.5-99.7) | 0.329c |
Comorbidities, n(%) | |||
 - Hypertension | 25 (83.3) | 25 (83.3) | 0.635d |
 - Diabetes | 11 (36.7) | 8 (26.7) | 0.405a |
 - Heart failure | 5 (16.7) | 5 (16.7) | 0.635d |
 - Coronary heart disease | 4 (14.3) | 2 (6.7) | 0.335d |
 - Stroke | 1 (3.3) | 3 (10) | 0.306d |
Medication taken, n(%) | |||
 - ACEi/ARB | 12 (40.0) | 14 (46.7) | 0.602a |
 - CCB | 20 (66.7) | 18 (60.0) | 0.592a |
 - Beta blocker | 3 (10.0) | 9 (30) | 0.053a |
 - Alpha blocker | 14 (46.7) | 9 (30) | 0.184a |
 - Insulin | 8 (26.7) | 3 (10) | 0.095a |
 - Oral hypoglycaemic drugs | 3 (10.0) | 4 (13.3) | 0.500d |
 - Phosphate binder | 28 (93.3) | 27 (90.0) | 0.640d |
 - Oral iron supplements | 1 (3.3) | 3 (10.0) | 0.306d |
HD adequacy (Kt/V), mean (SD) | 1.92 (0.35) | 1.83 (0.30) | 0.284b |
Body mass index (kg/m2), mean (SD) | 22.56 (4.80) | 24.22 (4.64) | 0.180b |
Laboratory | |||
 - Haemoglobin (g/dL), median (IQR) | 9.4 (7.9-10.9) | 9.4 (8.80-10.42) | 0.487c |
 - Leucocyte (/uL), mean (SD) | 8142 (2380.9) | 7978 (1783.9) | 0.764b |
 - Thrombocyte (/uL), mean (SD) | 257933.33 (61952.11) | 244433.33 (63318.39) | 0.407b |
 - Albumin (mg/dL), mean (SD) | 3.90 (0.28) | 3.87 (0.4) | 0.789b |
 - Urea (mg/dL), mean (SD) | 144.77 (44.83) | 131.94 (38.45) | 0.148b |
 - Creatinine (mg/dL), mean (SD) | 11.86 (3.46) | 12.35 (3.7) | 0.547b |
Dietary intake | |||
 - Calories (kcal/kg/day), median (IQR) | 28.82 (22.32-36.34) | 26.84 (18.41-36.21) | 0.220c |
 - Protein (gram/kg/day), mean (SD) | 0.91 (0.38) | 0.79 (0.30) | 0.178b |
 - Carbohydrate (gram/day), mean (SD) | 183.98 (71.05) | 206.99 (94.99) | 0.293b |
 - Fat (gram/day), mean (SD) | 70.02 (20.9) | 64.49 (20.51) | 0.306b |
 - Fibre (gram/day), mean (SD) | 6.09 (3.76) | 6.11 (3.33) | 0.980b |
Indoxyl sulphate (mg/L), median (IQR) | 26.98 (22.78-34.77) | 20.95 (17.25-27.07) | 0.062c |
PAC-SYM score, median (IQR) | 8 (5-11.25) | 6 (4-9.5) | 0.137c |
PAC-QOL score, median (IQR) | 17.5 (14-24) | 18 (13-26.25) | 0.970c |